SL
AZN icon

Salomon & Ludwin’s AstraZeneca AZN Stock Holding History

Salomon & Ludwin’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137K Buy
674
+75
+13% +$14.5K 0.01% 196
2025
Q4 		$109K Buy
599
+216
+56% +$37.9K 0.01% 227
2025
Q3 		$65.3K Buy
383
+347
+964% +$52.5K 0.01% 315
2025
Q2 		$5.12K Buy
36
+20
+125% +$2.8K ﹤0.01% 563
2025
Q1 		$2.35K Sell
16
-21
-57% -$3.04K ﹤0.01% 576
2024
Q4 		$4.85K Hold
37
– – ﹤0.01% 518
2024
Q3 		$5.76K Hold
37
– – ﹤0.01% 513
2024
Q2 		$5.77K Hold
37
– – ﹤0.01% 513
2024
Q1 		$5.01K Buy
+37
New +$4.9K ﹤0.01% 635

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Salomon & Ludwin's AZN Position: Q1 2026 in Review

Salomon & Ludwin increased its AstraZeneca (AZN) stake by 13% in Q1 2026, buying an estimated $14.5K and bringing the position to 674 shares worth $137K. The position accounts for 0.01% of the portfolio, ranked #196.

Salomon & Ludwin first reported a position in AZN in Q1 2024 and has held it in 9 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Salomon & Ludwin held 674 shares of AstraZeneca worth $137K as of Q1 2026.
  • Salomon & Ludwin bought 75 AstraZeneca shares in Q1 2026, an estimated $14.5K.
  • AstraZeneca made up 0.01% of Salomon & Ludwin's portfolio in Q1 2026, its #196 holding.
  • Salomon & Ludwin first reported a position in AstraZeneca in Q1 2024 and has held it in 9 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.